Lukas Hainz

Imagine a world where a simple leaf extract from an ancient tree could offer a safer and more effective treatment for pain and arthritis, potentially revolutionizing how we manage these chronic conditions. This scenario is not far-fetched, thanks to groundbreaking research on the medicinal

A significant breakthrough in the understanding of autism spectrum disorder (ASD) has recently emerged, shedding light on the genetic factors linked to this complex condition and its male predominance. Conducted by researchers from The Hospital for Sick Children (SickKids) in Canada and the

The human brain's ability to process sensory information is a marvel of biological engineering. Recent research from Harvard Medical School has uncovered new insights into how the brain processes touch and hearing simultaneously, revealing a complex interplay between these senses that enhances

Recent research has delved into the cognitive limitations of large language models (LLMs), or "chatbots," when subjected to dementia screening tests traditionally used on humans. The study, published in the Christmas issue of The BMJ, reveals that almost all leading LLMs exhibit signs of

The recent announcement by Russia regarding the development of a groundbreaking mRNA cancer vaccine represents a significant milestone in the global fight against cancer. Scheduled for free distribution in early 2025, this innovative vaccine has captured worldwide attention due to its potential to

The trial of handheld translation devices in a network of eight GP surgeries in Southampton has demonstrated impressive results, paving the way for improved communication with 5,850 non-English-speaking patients. This innovative trial spanned several months, from April 2024 to August 2024, and was

MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of

The effectiveness of cannabidiol (CBD) in reducing anxiety among patients with advanced breast cancer has become an intriguing subject for researchers, especially in the context of scan-related anxiety. A recent study conducted by researchers from the Dana-Farber Cancer Institute and Mass General

In early 2023, the FDA's announcement of a shortage of two critical generic platinum chemotherapy drugs, cisplatin and carboplatin, alarmed the medical community. These drugs have been essential in the treatment of various advanced cancers for over 30 years, particularly lung, head and neck,

The Keck School of Medicine of USC has embarked on a groundbreaking research initiative aimed at addressing age-related cognitive decline in women. This significant effort is led by Dr. Young-Kwon Hong and has been bolstered by securing a $3.4 million federal grant from the Advanced Research